FDA issued a Warning Letter to Praxair Inc. on 1/7/2015 as a result of this inspection.
483 Praxair Aug 2014

483 Praxair Aug 2014

Jacqueline Warner FDA$119.00 - Available Now

FDA investigators audited the Praxair - Tonawanda, NY, United States facility and issued inspectional observations (via FDA 483) on 08 Aug 2014.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 08 Aug 2014
  • Location: Tonawanda, United States
  • FEI: 1000448358
Add To Cart